Today Columbus Venture Partners announces the creation of Syngoi Technologies, a biotechnology company engaged in the production of synthetic DNA through a new enzymatic process, owned by the company, that addresses the needs of advanced therapies where DNA is the fundamental starting material. This is the case of gene therapy and mRNA-based vaccines, emerging therapeutic strategies where manufacturing is an...Read more
With the new investment fund, the managers plan to build two new plants in San Sebastian Columbus Venture Partners already has its second fund ready to invest in companies related to health sciences. It is in the registration phase at the National Securities Market Commission (CNMV) and will be operational shortly. The expected volume is 70 million euros, reports Expansión. According to...Read more
Latest innovations and first-hand business models
The Basque Country, with a long culinary tradition, has become a benchmark in the production of high quality food and drink, as well as for innovation in food technologies and in promoting the local culinary heritage. Business development and boosting the setting up of new companies and businesses are two of the Basque Government's fundamental commitments to strengthen and grow the food and gastronomic value chain, which is a strategic sector for the Basque economy. The efforts to strengthen...Read more
